Open label
Showing 26 - 50 of >10,000
Insomnia, Insomnia Chronic, Chloral Hydrate Trial (Chloral Hydrate)
Not yet recruiting
- Insomnia
- +2 more
- Chloral Hydrate
- (no location specified)
Sep 19, 2023
Systemic Lupus Erythematosus, Lupus Nephritis Trial in Boston (CABA-201)
Recruiting
- Systemic Lupus Erythematosus
- Lupus Nephritis
- CABA-201
-
Boston, MassachusettsMassachusetts General Hospital
Nov 7, 2023
Open Label Optimization Study
Not yet recruiting
- Major Depressive Disorder
- SAINT® Neuromodulation System (NMS)
-
Sunnyvale, CaliforniaAcacial Research Center
Apr 17, 2023
Metastatic Breast Cancer Trial in Amman (Fulvestrant injection)
Completed
- Metastatic Breast Cancer
- Fulvestrant injection
-
Amman, JordanTriumpharma Cro
Oct 3, 2023
Hypertension, Elevated Blood Pressure Trial (Vascanox® HP)
Not yet recruiting
- Hypertension
- Elevated Blood Pressure
- Vascanox® HP
- (no location specified)
Jun 26, 2023
Heel Spur Trial in Brno (Standard fractioned dose, Experimental single dose)
Recruiting
- Heel Spur
- Standard fractioned dose
- Experimental single dose
-
Brno, CzechiaMasaryk Memorial Cancer Institute
Oct 30, 2023
Amyotrophic Lateral Sclerosis Trial in Barcelona (FAB122)
Recruiting
- Amyotrophic Lateral Sclerosis
-
Barcelona, SpainHospital Universitari de Bellvitge
May 10, 2023
Cytomegalovirus Infections, Transplant-Related Disorder Trial in Philadelphia (Letermovir 480 MG [Prevymis])
Not yet recruiting
- Cytomegalovirus Infections
- Transplant-Related Disorder
- Letermovir 480 MG [Prevymis]
-
Philadelphia, PennsylvaniaPenn Medicine at the University of Pennsylvania
Sep 27, 2023
Acute Respiratory Distress Syndrome (ARDS) Trial (Glycolic acid tetrasubstituted piceatannol (TGKP))
Not yet recruiting
- Acute Respiratory Distress Syndrome (ARDS)
- Glycolic acid tetrasubstituted piceatannol (TGKP)
- (no location specified)
Nov 10, 2023
Phenylketonurias Trial (PKU GOLIKE)
Not yet recruiting
- Phenylketonurias
- PKU GOLIKE
- (no location specified)
Apr 12, 2023
Contraception Trial in San Martino (Female Contraceptive)
Recruiting
- Contraception
- Female Contraceptive
-
San Martino, Genova, ItalyIRCCS Ospedale Policlinico
Sep 28, 2023
HR+/HER2-breast Cancer Trial (Standard endocrine therapy plus Apatinib)
Not yet recruiting
- HR+/HER2-breast Cancer
- Standard endocrine therapy plus Apatinib
- (no location specified)
Jun 2, 2023
Idiopathic Inflammatory Myopathy, Dermatomyositis, Anti-Synthetase Syndrome Trial in Orange (CAB-201 following preconditioning
Recruiting
- Idiopathic Inflammatory Myopathy
- +3 more
- CAB-201 following preconditioning with fludarabine and cyclophosphamide
-
Orange, CaliforniaUniversity of California Irvine
Nov 30, 2023
PHN - Post-Herpetic Neuritis Trial in Beijing (HSK16149,probenecid, cimetidine)
Recruiting
- PHN - Post-Herpetic Neuritis
- HSK16149,probenecid, cimetidine
-
Beijing, ChinaBeijing Jishuitan Hoispital
May 21, 2023
Autism Spectrum Disorder Trial in Staten Island (ML-004 (IR)/(ER) tablet)
Recruiting
- Autism Spectrum Disorder
- ML-004 (IR)/(ER) tablet
-
Staten Island, New YorkRichmond Behavioral Associates
Jun 1, 2023
Epileptic Spasms, Failed Hormonal Therapy Trial in New Delhi (Modified Atkins diet, Topiramate)
Recruiting
- Epileptic Spasms, Failed Hormonal Therapy
- Modified Atkins diet
- Topiramate
-
New Delhi, Delhi, IndiaLady Hardinge Medical College and Associated Kalawati Saran Chil
Jul 14, 2023
Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)
Not yet recruiting
- Acute Myeloid Leukemia in Children
- Standard Intervention
- Investigational Intervention
- (no location specified)
Aug 8, 2023
Healthy Adult Subjects Trial in Tempe (Omaveloxolone, Efavirenz)
Not yet recruiting
- Healthy Adult Subjects
-
Tempe, ArizonaCelerion, Inc.
Jun 16, 2023
Healthy Participants Trial (Darigabat, Carbamazepine)
Not yet recruiting
- Healthy Participants
- (no location specified)
Apr 11, 2023
Prostatic Adenocarcinoma Trial in Seoul (Enzalutamide)
Not yet recruiting
- Prostatic Adenocarcinoma
-
Seoul, Korea, Korea, Republic ofSamsung Medical Center
Aug 23, 2023